Share the Video:

The drug policy endgame: beyond public health

Shaleen Title, Kassandra Frederique, Jason Ortiz

Prepare to be immersed in a thought-provoking discussion led by seasoned and visionary leaders, experts, and activists about challenging the status quo and redefining the parameters of drug policy. This opening session will explore the multifaceted dimensions that extend beyond public health like social and transformative justice, civil and human rights, and lasting systemic reform. We’ll discuss practical and principled approaches that prioritize harm reduction, community empowerment, and transformative justice. We seek a world where drug policy transcends its traditional boundaries, leading us towards a future of compassion, equity, and holistic well-being for all – join us!

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Proactive harm reduction by preparing set, setting, and substance

Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.

Mitchell Gomez, Phoenix aka Mohawk Greene

PS2023 Health Equity Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Psychedelic social equity, criminal justice, and sentencing reform

Visionary advocates, activists, and policy experts discuss rectifying historical injustices and disparities from psychedelic criminalization. Conversations focus on social equity, criminal justice reform, and sentencing for legal infrastructure changes.

Kellen Russoniello, Rachel Knox, Sia Henry

PS2023 Harm Reduction LSD Policy and Advocacy Psychedelic Science Research Social Justice

Underground History and Overground Future

William Leonard Pickard, once a prominent figure in the drug world, served 20 years in prison for LSD production and now works as a senior advisor for various organizations. His

William Leonard Pickard, Vince Kadlubek

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Visionary approaches: psychedelic policy in a global context

International drug policy, historically mirroring US prohibitionist approach, is evolving. Leaders propose regulatory solutions in context of broader drug reform for unified post-prohibition world.

Steve Rolles, Kasia Malinowska

PS2023 Policy Policy and Advocacy Public Benefit Research Social Justice

Perspectives on the landscape of state and federal reform

Experts and advocates discuss the intricacies of psychedelic policy reform at state and federal levels, highlighting federalism, grassroots movements, expert leverage, and collaborative approaches for equitable drug policies.

Matt C Zorn, Ismail Ali, Brett Waters, Seema Sadanandan, Kathryn L Tucker

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

The drug policy endgame: beyond public health

Become a MAPS Member with a monthly donation

Related Videos